Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Mar;71(3):369–376.

The influence of cyclosporin A on cell-mediated immunity.

A W Thomson 1, L M Webster 1
PMCID: PMC1541682  PMID: 2968199

Full text

PDF
369

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aiello F. B., Maggiano N., Larocca L. M., Piantelli M., Musiani P. Inhibitory effect of cyclosporin A on the OKT3-induced peripheral blood lymphocyte proliferation. Cell Immunol. 1986 Jan;97(1):131–139. doi: 10.1016/0008-8749(86)90382-5. [DOI] [PubMed] [Google Scholar]
  2. Alberti S., Boraschi D., Luini W., Tagliabue A. Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses. Int J Immunopharmacol. 1981;3(4):357–364. doi: 10.1016/0192-0561(81)90031-x. [DOI] [PubMed] [Google Scholar]
  3. Aldridge R. D., Thomson A. W. Factors influencing the enhancement of delayed-type hypersensitivity to ovalbumin by cyclosporin A in the guinea pig: possible role of suppressor cells. Int Arch Allergy Appl Immunol. 1986;81(1):17–23. doi: 10.1159/000234101. [DOI] [PubMed] [Google Scholar]
  4. Aldridge R. D., Thomson A. W. Paradoxical augmentation of tuberculin-like hypersensitivity, but not Jones-Mote or contact hypersensitivity, in cyclosporin A treated guinea pigs. Int Arch Allergy Appl Immunol. 1986;79(3):225–230. doi: 10.1159/000233977. [DOI] [PubMed] [Google Scholar]
  5. Altmann D. M., Blyth W. A. The effects of cyclosporin A on the induction, expression and regulation of the immune response to herpes simplex virus. Clin Exp Immunol. 1985 Jan;59(1):17–22. [PMC free article] [PubMed] [Google Scholar]
  6. Andrus L., Lafferty K. J. Inhibition of T-cell activity by cyclosporin A. Scand J Immunol. 1981 May;15(5):449–458. doi: 10.1111/j.1365-3083.1982.tb00670.x. [DOI] [PubMed] [Google Scholar]
  7. Bendtzen K., Petersen J. Effect of cyclosporin A (CyA) on the immune response. CyA competitively inhibits the function of monocyte/macrophage-derived T-lymphocyte-activating factor(s). Immunol Lett. 1982;5(6):331–336. doi: 10.1016/0165-2478(82)90123-7. [DOI] [PubMed] [Google Scholar]
  8. Bennett W. M., Norman D. J. Action and toxicity of cyclosporine. Annu Rev Med. 1986;37:215–224. doi: 10.1146/annurev.me.37.020186.001243. [DOI] [PubMed] [Google Scholar]
  9. Bettens F., Walker C., Bonnard G. D., de Weck A. L. Effect of cyclosporin A on the early activation of human T helper lymphocytes: inhibition of RNA-synthesis and modification of the expression of activation antigens. Immunobiology. 1985 Dec;170(5):434–447. doi: 10.1016/S0171-2985(85)80067-X. [DOI] [PubMed] [Google Scholar]
  10. Bijsterbosch M. K., Klaus G. G. Cyclosporine does not inhibit mitogen-induced inositol phospholipid degradation in mouse lymphocytes. Immunology. 1985 Nov;56(3):435–440. [PMC free article] [PubMed] [Google Scholar]
  11. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  12. Borel J. F., Feurer C., Magnée C., Stähelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017–1025. [PMC free article] [PubMed] [Google Scholar]
  13. Braida M., Knop J. Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity. Immunology. 1986 Dec;59(4):503–507. [PMC free article] [PubMed] [Google Scholar]
  14. Britton S., Palacios R. Cyclosporin A--usefulness, risks and mechanism of action. Immunol Rev. 1982;65:5–22. doi: 10.1111/j.1600-065x.1982.tb00425.x. [DOI] [PubMed] [Google Scholar]
  15. Bucy R. P. Alloantigen-specific suppressor T cells are not inhibited by cyclosporin A, but do require IL 2 for activation. J Immunol. 1986 Aug 1;137(3):809–813. [PubMed] [Google Scholar]
  16. Bunjes D., Hardt C., Röllinghoff M., Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol. 1981 Aug;11(8):657–661. doi: 10.1002/eji.1830110812. [DOI] [PubMed] [Google Scholar]
  17. Calne R. Y. Immunosuppression for organ grafting -- observations on cyclosporin A. Immunol Rev. 1979;46:113–124. doi: 10.1111/j.1600-065x.1979.tb00286.x. [DOI] [PubMed] [Google Scholar]
  18. Calne R. Y. Pancreas transplantation. Prog Allergy. 1986;38:395–403. [PubMed] [Google Scholar]
  19. Carlesen E., Prydz H. Enhancement of procoagulant activity in stimulated mononuclear blood cells and monocytes by cyclosporine. Transplantation. 1987 Apr;43(4):543–548. doi: 10.1097/00007890-198704000-00018. [DOI] [PubMed] [Google Scholar]
  20. Carlsen E., Mallet A. C., Prydz H. Effect of cyclosporine A on procoagulant activity in mononuclear blood cells and monocytes in vitro. Clin Exp Immunol. 1985 May;60(2):407–416. [PMC free article] [PubMed] [Google Scholar]
  21. Chisholm P. M., Drayson M. T., Cox J. H., Ford W. L. The effects of cyclosporin on lymphocyte activation in a systemic graft-vs.-host reaction. Eur J Immunol. 1985 Oct;15(10):1054–1059. doi: 10.1002/eji.1830151018. [DOI] [PubMed] [Google Scholar]
  22. Colombani P. M., Robb A., Hess A. D. Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes. Science. 1985 Apr 19;228(4697):337–339. doi: 10.1126/science.3885394. [DOI] [PubMed] [Google Scholar]
  23. Converse P. J., Hess A. D. Effect of cyclosporin and interleukin-2 on the restoration of in vitro immune responses to cytomegalovirus. Scand J Immunol. 1985 Feb;21(2):109–118. doi: 10.1111/j.1365-3083.1985.tb01409.x. [DOI] [PubMed] [Google Scholar]
  24. Cox J. H., Chisholm P. M. Mechanism of action of cyclosporine in preventing cardiac allograft rejection. I. Rate of entry of lymphocytes from the blood, fibrin deposition, and expression of Ia antigens on infiltrating cells. Transplantation. 1987 Mar;43(3):338–342. [PubMed] [Google Scholar]
  25. Cox J. H., Forsyth A. T., de Villiers J. S., Yacoub M. H., Chisholm P. M. The kinetics and specificity of lymphocyte infiltration of cardiac allografts in unmodified and cyclosporin-treated rats. Transplantation. 1984 Jul;38(1):17–22. doi: 10.1097/00007890-198407000-00004. [DOI] [PubMed] [Google Scholar]
  26. Damjanovich S., Aszalos A., Mulhern S., Balazs M., Matyus L. Cytoplasmic membrane potential of mouse lymphocytes is decreased by cyclosporins. Mol Immunol. 1986 Feb;23(2):175–180. doi: 10.1016/0161-5890(86)90040-4. [DOI] [PubMed] [Google Scholar]
  27. Diamantstein T., Volk H. D., Tilney N. L., Kupiec-Weglinski J. Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin. Immunobiology. 1986 Sep;172(3-5):391–399. doi: 10.1016/S0171-2985(86)80120-6. [DOI] [PubMed] [Google Scholar]
  28. Dos Reis G. A., Shevach E. M. Effect of cyclosporin A on T cell function in vitro: the mechanism of suppression of T cell proliferation depends on the nature of the T cell stimulus as well as the differentiation state of the responding T cell. J Immunol. 1982 Dec;129(6):2360–2367. [PubMed] [Google Scholar]
  29. Drath D. B., Kahan B. D. Phagocytic cell function in response to immunosuppressive therapy. Arch Surg. 1984 Feb;119(2):156–160. doi: 10.1001/archsurg.1984.01390140022004. [DOI] [PubMed] [Google Scholar]
  30. Dunn C. J., Miller S. K. The effects of cyclosporin A on leucocyte infiltration and procoagulant activity in the mouse delayed hypersensitivity response in vivo. Int J Immunopharmacol. 1986;8(6):635–643. doi: 10.1016/0192-0561(86)90036-6. [DOI] [PubMed] [Google Scholar]
  31. Elliott J. F., Lin Y., Mizel S. B., Bleackley R. C., Harnish D. G., Paetkau V. Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science. 1984 Dec 21;226(4681):1439–1441. doi: 10.1126/science.6334364. [DOI] [PubMed] [Google Scholar]
  32. Espevik T., Figari I. S., Shalaby M. R., Lackides G. A., Lewis G. D., Shepard H. M., Palladino M. A., Jr Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med. 1987 Aug 1;166(2):571–576. doi: 10.1084/jem.166.2.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Ferrini S., Moretta A., Biassoni R., Nicolin A., Moretta L. Cyclosporin-A inhibits IL-2 production by all human T-cell clones having this function, independent of the T4/T8 phenotype or the coexpression of cytolytic activity. Clin Immunol Immunopathol. 1986 Jan;38(1):79–84. doi: 10.1016/0090-1229(86)90124-8. [DOI] [PubMed] [Google Scholar]
  34. Fidelus R. K., Laughter A. H., Twomey J. J., Taffet S. M., Haddox M. K. The effect of cyclosporine on ornithine decarboxylase induction with mitogens, antigens, and lymphokines. Transplantation. 1984 Apr;37(4):383–387. doi: 10.1097/00007890-198404000-00014. [DOI] [PubMed] [Google Scholar]
  35. Freed B. M., Rosano T. G., Lempert N. In vitro immunosuppressive properties of cyclosporine metabolites. Transplantation. 1987 Jan;43(1):123–127. doi: 10.1097/00007890-198701000-00027. [DOI] [PubMed] [Google Scholar]
  36. Gelfand E. W., Cheung R. K., Mills G. B. The cyclosporins inhibit lymphocyte activation at more than one site. J Immunol. 1987 Feb 15;138(4):1115–1120. [PubMed] [Google Scholar]
  37. Gordon M. Y., Singer J. W. Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man. Nature. 1979 May 31;279(5712):433–434. doi: 10.1038/279433a0. [DOI] [PubMed] [Google Scholar]
  38. Granelli-Piperno A., Andrus L., Steinman R. M. Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med. 1986 Apr 1;163(4):922–937. doi: 10.1084/jem.163.4.922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Granelli-Piperno A., Inaba K., Steinman R. M. Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. J Exp Med. 1984 Dec 1;160(6):1792–1802. doi: 10.1084/jem.160.6.1792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Gratwohl A., Speck B. Bone marrow transplantation with ciclosporin. Prog Allergy. 1986;38:404–431. [PubMed] [Google Scholar]
  41. Green C. J. Experimental transplantation. Prog Allergy. 1986;38:123–158. doi: 10.1159/000412396. [DOI] [PubMed] [Google Scholar]
  42. Gui X. E., Rinaldo C. R., Jr, Ho M. Natural killer cell activity in renal transplant recipients receiving cyclosporine. Infect Immun. 1983 Sep;41(3):965–970. doi: 10.1128/iai.41.3.965-970.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Hait W. N., Harding M. W., Handschumacher R. E. Calmodulin, cyclophilin, and cyclosporin A. Science. 1986 Aug 29;233(4767):987–989. doi: 10.1126/science.3016900. [DOI] [PubMed] [Google Scholar]
  44. Hancock W. W., Lord R. H., Colby A. J., Diamantstein T., Rickles F. R., Dijkstra C., Hogg N., Tilney N. L. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. J Immunol. 1987 Jan 1;138(1):164–170. [PubMed] [Google Scholar]
  45. Handschumacher R. E., Harding M. W., Rice J., Drugge R. J., Speicher D. W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 1984 Nov 2;226(4674):544–547. doi: 10.1126/science.6238408. [DOI] [PubMed] [Google Scholar]
  46. Heeg K., Deusch K., Solbach W., Bunjes D., Wagner H. Frequency analysis of cyclosporine-sensitive cytotoxic T lymphocyte precursors. Transplantation. 1984 Nov;38(5):532–536. doi: 10.1097/00007890-198411000-00019. [DOI] [PubMed] [Google Scholar]
  47. Helin H. J., Edgington T. S. Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells: inhibition of monocyte procoagulant response to allogeneic stimulation. J Immunol. 1984 Mar;132(3):1074–1076. [PubMed] [Google Scholar]
  48. Herold K. C., Lancki D. W., Moldwin R. L., Fitch F. W. Immunosuppressive effects of cyclosporin A on cloned T cells. J Immunol. 1986 Feb 15;136(4):1315–1321. [PubMed] [Google Scholar]
  49. Hess A. D., Colombani P. M. Cyclosporin. Mechanism of action: in vitro studies. Prog Allergy. 1986;38:198–221. [PubMed] [Google Scholar]
  50. Hess A. D., Tutschka P. J. Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR. J Immunol. 1980 Jun;124(6):2601–2608. [PubMed] [Google Scholar]
  51. Hess A. D., Tutschka P. J., Santos G. W. Effect of cyclosporin A on human lymphocyte responses in vitro. II. Induction of specific alloantigen unresponsiveness mediated by a nylon wool adherent suppressor cell. J Immunol. 1981 Mar;126(3):961–968. [PubMed] [Google Scholar]
  52. Hess A. D., Tutschka P. J., Santos G. W. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF. J Immunol. 1982 Jan;128(1):355–359. [PubMed] [Google Scholar]
  53. Hiestand P. C. Cyclosporin A (Sandimmun) modulates the Ca2+ uptake of mitogen-stimulated lymphocytes. Agents Actions. 1984 Dec;15(5-6):556–561. doi: 10.1007/BF01966774. [DOI] [PubMed] [Google Scholar]
  54. Hodgkin P. D., Hapel A. J., Johnson R. M., Young I. G., Lafferty K. J. Blocking of delivery of the antigen-mediated signal to the nucleus of T cells by cyclosporine. Transplantation. 1987 May;43(5):685–692. doi: 10.1097/00007890-198705000-00017. [DOI] [PubMed] [Google Scholar]
  55. Hutchinson I. F., Shadur C. A., Duarte J. S., Strom T. B., Tilney N. L. Cyclosporin A spares selectively lymphocytes with donor-specific suppressor characteristics. Transplantation. 1981 Sep;32(3):210–216. doi: 10.1097/00007890-198109000-00006. [DOI] [PubMed] [Google Scholar]
  56. Introna M., Allavena P., Spreafico F., Mantovani A. Inhibition of human natural killer activity by cyclosporin A. Transplantation. 1981 Feb;31(2):113–116. doi: 10.1097/00007890-198102000-00004. [DOI] [PubMed] [Google Scholar]
  57. Janco R. L., English D. Cyclosporine and human neutrophil function. Transplantation. 1983 May;35(5):501–503. doi: 10.1097/00007890-198305000-00023. [DOI] [PubMed] [Google Scholar]
  58. Kahan B. D. Cyclosporine: the agent and its actions. Transplant Proc. 1985 Aug;17(4 Suppl 1):5–18. [PubMed] [Google Scholar]
  59. Kalman V. K., Klimpel G. R. Cyclosporin A inhibits the production of gamma interferon (IFN gamma), but does not inhibit production of virus-induced IFN alpha/beta. Cell Immunol. 1983 May;78(1):122–129. doi: 10.1016/0008-8749(83)90265-4. [DOI] [PubMed] [Google Scholar]
  60. Kaufmann Y., Chang A. E., Robb R. J., Rosenberg S. A. Mechanism of action of Cyclosporin A: inhibition of lymphokine secretion studied with antigen-stimulated T cell hybridomas. J Immunol. 1984 Dec;133(6):3107–3111. [PubMed] [Google Scholar]
  61. Kay J. E., Benzie C. R., Borghetti A. F. Effect of cyclosporin A on lymphocyte activation by the calcium ionophore A23187. Immunology. 1983 Nov;50(3):441–446. [PMC free article] [PubMed] [Google Scholar]
  62. Kay J. E. The cyclosporin-A-sensitive event in lymphocyte activation. Ann Inst Pasteur Immunol. 1987 Jul-Aug;138(4):622–625. doi: 10.1016/s0769-2625(87)80134-4. [DOI] [PubMed] [Google Scholar]
  63. Kermani-Arab V., Salehmoghaddam S., Danovitch G., Hirji K., Rezai A. Mediation of the antiproliferative effect of cyclosporine on human lymphocytes by blockade of interleukin 2 biosynthesis. Transplantation. 1985 Apr;39(4):439–442. doi: 10.1097/00007890-198504000-00019. [DOI] [PubMed] [Google Scholar]
  64. Kharazmi A., Svenson M., Nielsen H., Birgens H. S. Effect of cyclosporin A on human neutrophil and monocyte function. Scand J Immunol. 1985 Jun;21(6):585–591. doi: 10.1111/j.1365-3083.1985.tb01848.x. [DOI] [PubMed] [Google Scholar]
  65. Klaus G. G., Hawrylowicz C. M. Activation and proliferation signals in mouse B cells. II. Evidence for activation (G0 to G1) signals differing in sensitivity to cyclosporine. Eur J Immunol. 1984 Mar;14(3):250–254. doi: 10.1002/eji.1830140309. [DOI] [PubMed] [Google Scholar]
  66. Knight S. C., Balfour B., O'Brien J., Buttifant L. Sensitivity of veiled (dendritic) cells to cyclosporine. Transplantation. 1986 Jan;41(1):96–100. doi: 10.1097/00007890-198601000-00019. [DOI] [PubMed] [Google Scholar]
  67. Koponen M., Grieder A., Loor F. The effects of cyclosporins on the cell cycle of t-lymphoid cell lines. Exp Cell Res. 1982 Aug;140(2):237–250. doi: 10.1016/0014-4827(82)90111-2. [DOI] [PubMed] [Google Scholar]
  68. Koponen M., Loor F. Cytoplasmic lipid droplets as the possible eventual cellular fate of active forms of cyclosporin. Exp Cell Res. 1983 Dec;149(2):499–512. doi: 10.1016/0014-4827(83)90361-0. [DOI] [PubMed] [Google Scholar]
  69. Krönke M., Leonard W. J., Depper J. M., Arya S. K., Wong-Staal F., Gallo R. C., Waldmann T. A., Greene W. C. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5214–5218. doi: 10.1073/pnas.81.16.5214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Kupiec-Weglinski J. W., Filho M. A., Strom T. B., Tilney N. L. Sparing of suppressor cells: a critical action of cyclosporine. Transplantation. 1984 Aug;38(2):97–101. doi: 10.1097/00007890-198408000-00001. [DOI] [PubMed] [Google Scholar]
  71. Land W., Castro L. A., White D. J., Hillebrand G., Hammer C., Klare B., Fornara P. Ciclosporin in renal transplantation. Prog Allergy. 1986;38:293–328. [PubMed] [Google Scholar]
  72. Landegren U., Wigzell H. Cyclosporin A inhibits a discrete step in T-lymphocyte stimulation. Scand J Immunol. 1985 Sep;22(3):279–284. doi: 10.1111/j.1365-3083.1985.tb01882.x. [DOI] [PubMed] [Google Scholar]
  73. Larson D. F. Cyclosporin. Mechanism of action: antagonism of the prolactin receptor. Prog Allergy. 1986;38:222–238. [PubMed] [Google Scholar]
  74. Larsson E. L. Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process. J Immunol. 1980 Jun;124(6):2828–2833. [PubMed] [Google Scholar]
  75. LeGrue S. J., Friedman A. W., Kahan B. D. Binding of cyclosporine by human lymphocytes and phospholipid vesicles. J Immunol. 1983 Aug;131(2):712–718. [PubMed] [Google Scholar]
  76. LeGrue S. J., Turner R., Weisbrodt N., Dedman J. R. Does the binding of cyclosporine to calmodulin result in immunosuppression? Science. 1986 Oct 3;234(4772):68–71. doi: 10.1126/science.3749892. [DOI] [PubMed] [Google Scholar]
  77. Leapman S. B., Filo R. S., Smith E. J., Smith P. G. In vitro effects of cyclosporin A on lymphocyte subpopulations. 1. Suppressor cell sparing by cyclosporin A. Transplantation. 1980 Dec;30(6):404–408. doi: 10.1097/00007890-198012000-00003. [DOI] [PubMed] [Google Scholar]
  78. Leapman S. B., Strong D. M., Filo R. S., Smith E. J., Brandt G. L. Cyclosporin A prevents the appearance of cell surface "activation" antigens. Transplantation. 1982 Aug;34(2):94–95. [PubMed] [Google Scholar]
  79. Lillehoj H. S., Malek T. R., Shevach E. M. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens. J Immunol. 1984 Jul;133(1):244–250. [PubMed] [Google Scholar]
  80. Liversidge J., Sewell H. F., Thomson A. W., Forrester J. V. Lymphokine-induced MHC class II antigen expression on cultured retinal pigment epithelial cells and the influence of cyclosporin A. Immunology. 1988 Feb;63(2):313–317. [PMC free article] [PubMed] [Google Scholar]
  81. Marder P., Schmidtke J. R. Cyclosporin A inhibits helper/inducer surface antigen expression on activated human lymphocytes. Int J Immunopharmacol. 1985;7(2):165–175. doi: 10.1016/0192-0561(85)90023-2. [DOI] [PubMed] [Google Scholar]
  82. Mathie I. H., Sewell H. F., Thomson A. W. Generation of large granular lymphocytes and lymphocyte subset changes linked with cyclophosphamide-induced eosinophilia in rats--and the effects of ciclosporin. Scand J Immunol. 1987 Oct;26(4):417–425. doi: 10.1111/j.1365-3083.1987.tb02274.x. [DOI] [PubMed] [Google Scholar]
  83. McGregor C. G., Oyer P. E., Shumway N. E. Heart and heart-lung transplantation. Prog Allergy. 1986;38:346–365. [PubMed] [Google Scholar]
  84. McIntosh L. C., Thompson A. W. Activity of the mononuclear phagocyte system in cyclosporin A-treated mice. Transplantation. 1980 Nov;30(5):384–386. doi: 10.1097/00007890-198011000-00017. [DOI] [PubMed] [Google Scholar]
  85. Metcalfe S. Cyclosporine does not prevent cytoplasmic calcium changes associated with lymphocyte activation. Transplantation. 1984 Aug;38(2):161–164. doi: 10.1097/00007890-198408000-00014. [DOI] [PubMed] [Google Scholar]
  86. Milon G., Truffa-Bachi P., Shidani B., Marchal G. Cyclosporin A inhibits the delayed-type hypersensitivity effector function of T lymphocytes without affecting their clonal expansion. Ann Immunol (Paris) 1984 Nov-Dec;135D(3):237–245. doi: 10.1016/s0769-2625(84)81188-5. [DOI] [PubMed] [Google Scholar]
  87. Miyawaki T., Yachie A., Ohzeki S., Nagaoki T., Taniguchi N. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells. J Immunol. 1983 Jun;130(6):2737–2742. [PubMed] [Google Scholar]
  88. Morris P. J. Cyclosporin A. Transplantation. 1981 Nov;32(5):349–354. [PubMed] [Google Scholar]
  89. Mottram P. L., Mirisklavos A., Dumble L. J., Clunie G. J. Effects of cyclosporin A, antilymphocyte serum and donor-specific transfusions on murine delayed-type hypersensitivity and skin graft survival. Int Arch Allergy Appl Immunol. 1986;79(3):296–304. doi: 10.1159/000233990. [DOI] [PubMed] [Google Scholar]
  90. Niwa Y., Kano T., Taniguchi S., Miyachi Y., Sakane T. Effect of cyclosporin A on the membrane-associated events in human leukocytes with special reference to the similarity with dexamethasone. Biochem Pharmacol. 1986 Mar 15;35(6):947–951. doi: 10.1016/0006-2952(86)90081-x. [DOI] [PubMed] [Google Scholar]
  91. Orosz C. G., Fidelus R. K., Roopenian D. C., Widmer M. B., Ferguson R. M., Bach F. H. Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A. J Immunol. 1982 Nov;129(5):1865–1868. [PubMed] [Google Scholar]
  92. Orosz C. G., Roopenian D. C., Widmer M. B., Bach F. H. Analysis of cloned T cell function. II. Differential blockade of various cloned T cell functions by cyclosporine. Transplantation. 1983 Dec;36(6):706–711. doi: 10.1097/00007890-198336060-00024. [DOI] [PubMed] [Google Scholar]
  93. Palacios R. Cyclosporin A inhibits antigen- and lectin-induced but not constitutive production of interleukin 3. Eur J Immunol. 1985 Feb;15(2):204–206. doi: 10.1002/eji.1830150220. [DOI] [PubMed] [Google Scholar]
  94. Palacios R., Martinez-Maza O., De Ley M. Production of human immune interferon (Hu IFN-gamma) studied at the single cell level. Origin, evidence for spontaneous secretion and effect of cyclosporin A. Eur J Immunol. 1983 Mar;13(3):221–225. doi: 10.1002/eji.1830130308. [DOI] [PubMed] [Google Scholar]
  95. Palacios R. Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins. Immunol Rev. 1982;63:73–110. doi: 10.1111/j.1600-065x.1982.tb00412.x. [DOI] [PubMed] [Google Scholar]
  96. Palacios R., Möller G. Cyclosporin A blocks receptors for HLA-DR antigens on T cells. Nature. 1981 Apr 30;290(5809):792–794. doi: 10.1038/290792a0. [DOI] [PubMed] [Google Scholar]
  97. Palay D. A., Cluff C. W., Wentworth P. A., Ziegler H. K. Cyclosporine inhibits macrophage-mediated antigen presentation. J Immunol. 1986 Jun 15;136(12):4348–4353. [PubMed] [Google Scholar]
  98. Parker D., Drössler K., Turk J. L. Kinetics of the effect of a single dose of cyclosporin-A on antibody and cell mediated immune responses in the guinea pig. Int J Immunopharmacol. 1984;6(1):67–74. doi: 10.1016/0192-0561(84)90037-7. [DOI] [PubMed] [Google Scholar]
  99. Pawelec G., Wernet P. Cyclosporin A inhibits interleukin 2-dependent growth of alloactivated cloned human T-lymphocytes. Int J Immunopharmacol. 1983;5(4):315–321. doi: 10.1016/0192-0561(83)90034-6. [DOI] [PubMed] [Google Scholar]
  100. Prince H. E., John J. K. Cyclosporine inhibits the expression of receptors for interleukin 2 and transferrin on mitogen-activated human T lymphocytes. Immunol Invest. 1986 Aug;15(5):463–472. doi: 10.3109/08820138609054917. [DOI] [PubMed] [Google Scholar]
  101. Reem G. H., Cook L. A., Vilcek J. Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science. 1983 Jul 1;221(4605):63–65. doi: 10.1126/science.6407112. [DOI] [PubMed] [Google Scholar]
  102. Rich S., Carpino M. R., Arhelger C. Suppressor T cell growth and differentiation. Identification of a cofactor required for suppressor T cell function and distinct from interleukin 2. J Exp Med. 1984 May 1;159(5):1473–1490. doi: 10.1084/jem.159.5.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Rosoff P. M., Terres G. Cyclosporine A inhibits Ca2+-dependent stimulation of the Na+/H+ antiport in human T cells. J Cell Biol. 1986 Aug;103(2):457–463. doi: 10.1083/jcb.103.2.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Russell D. H., Kibler R., Matrisian L., Larson D. F., Poulos B., Magun B. E. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol. 1985 May;134(5):3027–3031. [PubMed] [Google Scholar]
  105. Ryffel B., Donatsch P., Götz U., Tschopp M. Cyclosporin receptor on mouse lymphocytes. Immunology. 1980 Dec;41(4):913–919. [PMC free article] [PubMed] [Google Scholar]
  106. Ryffel B., Götz U., Heuberger B. Cyclosporin receptors on human lymphocytes. J Immunol. 1982 Nov;129(5):1978–1982. [PubMed] [Google Scholar]
  107. Ryffel B., Müller S., Foxwell B. Cyclosporine A allows the expression of high affinity interleukin 2 binding sites on anti-T-cell antibody activated human T lymphocytes. Transplant Proc. 1987 Feb;19(1 Pt 2):1199–1201. [PubMed] [Google Scholar]
  108. Ryffel B., Willard-Gallo K. E., Tammi K., Loken M. R. Quantitative fluorescence analysis of cyclosporine binding to human leukocytes. Transplantation. 1984 Mar;37(3):276–280. doi: 10.1097/00007890-198403000-00012. [DOI] [PubMed] [Google Scholar]
  109. Shao-Hsien C., Lang I., Gunn H., Lydyard P. Effect of in vitro cyclosporin. A treatment on human natural and antibody-dependent cell-mediated cytotoxicity. Transplantation. 1983 Feb;35(2):127–129. doi: 10.1097/00007890-198302000-00004. [DOI] [PubMed] [Google Scholar]
  110. Shevach E. M. The effects of cyclosporin A on the immune system. Annu Rev Immunol. 1985;3:397–423. doi: 10.1146/annurev.iy.03.040185.002145. [DOI] [PubMed] [Google Scholar]
  111. Shidani B., Milon G., Marchal G., Truffa-Bachi P. Cyclosporin A inhibits the delayed-type hypersensitivity reaction: impaired production of early pro-inflammatory mediator(s). Eur J Immunol. 1984 Apr;14(4):314–318. doi: 10.1002/eji.1830140407. [DOI] [PubMed] [Google Scholar]
  112. Shidani B., Motta I., Truffa-Bachi P. Cyclosporin A does not affect the in vitro induction of antigen-specific delayed-type hypersensitivity-mediating T cells. Eur J Immunol. 1987 Feb;17(2):291–294. doi: 10.1002/eji.1830170222. [DOI] [PubMed] [Google Scholar]
  113. Simons J. W., Noga S. J., Colombani P. M., Beschorner W. E., Coffey D. S., Hess A. D. Cyclosporine A, an in vitro calmodulin antagonist, induces nuclear lobulations in human T cell lymphocytes and monocytes. J Cell Biol. 1986 Jan;102(1):145–150. doi: 10.1083/jcb.102.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Starzl T. E., Iwatsuki S., Shaw B. W., Jr, Gordon R. D., Esquivel C. Liver transplantation in the ciclosporin era. Prog Allergy. 1986;38:366–394. doi: 10.1159/000318481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Stoeck M., Wildhagen K., Szamel M., Lovett D., Resch K. Studies on the mechanism whereby cyclosporin A inhibits T-lymphocyte activation. Immunobiology. 1985 Feb;169(1):83–96. doi: 10.1016/S0171-2985(85)80056-5. [DOI] [PubMed] [Google Scholar]
  116. Szamel M., Berger P., Resch K. Inhibition of T lymphocyte activation by cyclosporin A: interference with the early activation of plasma membrane phospholipid metabolism. J Immunol. 1986 Jan;136(1):264–269. [PubMed] [Google Scholar]
  117. Thomson A. W., Aldridge R. D. Absence of dependence on cyclophosphamide-sensitive suppressor cells in suppression of cell-mediated immunity by cyclosporine in the guinea pig. Transplantation. 1984 Jul;38(1):76–77. doi: 10.1097/00007890-198407000-00018. [DOI] [PubMed] [Google Scholar]
  118. Thomson A. W. Immunobiology of cyclosporin A--a review. Aust J Exp Biol Med Sci. 1983 Apr;61(Pt 2):147–172. doi: 10.1038/icb.1983.14. [DOI] [PubMed] [Google Scholar]
  119. Thomson A. W., Milton J. I., Aldridge R. D., Davidson R. J., Simpson J. G. Inhibition of drug-induced eosinophilia by cyclosporin A. Scand J Immunol. 1986 Aug;24(2):163–170. doi: 10.1111/j.1365-3083.1986.tb02082.x. [DOI] [PubMed] [Google Scholar]
  120. Thomson A. W., Moon D. K., Geczy C. L., Nelson D. S. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines. Immunology. 1983 Feb;48(2):291–299. [PMC free article] [PubMed] [Google Scholar]
  121. Thomson A. W., Moon D. K., Inoue Y., Geczy C. L., Nelson D. S. Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs. Immunology. 1983 Feb;48(2):301–308. [PMC free article] [PubMed] [Google Scholar]
  122. Thomson A. W., Moon D. K., Nelson D. S. Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse. Clin Exp Immunol. 1983 Jun;52(3):599–606. [PMC free article] [PubMed] [Google Scholar]
  123. Thomson A. W., Whiting P. H., Simpson J. G. Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions. 1984 Oct;15(3-4):306–327. doi: 10.1007/BF01972366. [DOI] [PubMed] [Google Scholar]
  124. Tosato G., Pike S. E., Koski I. R., Blaese R. M. Selective inhibition of immunoregulatory cell functions by cyclosporin A. J Immunol. 1982 May;128(5):1986–1991. [PubMed] [Google Scholar]
  125. Uhteg L. C., Salomon D. R., Rocher L. L., Kupiec-Weglinski J. W., Araujo J. L., Rubin M. F., Tilney N. L., Carpenter C. B. Cyclosporine-induced transplantation unresponsiveness in rat cardiac allograft recipients: in vitro determination of helper and suppressor activity. J Immunol. 1985 Sep;135(3):1800–1805. [PubMed] [Google Scholar]
  126. Wang B. S., Heacock E. H., Chang-Xue Z., Tilney N. L., Strom T. B., Mannick J. A. Evidence for the presence of suppressor T lymphocytes in animals treated with cyclosporin A. J Immunol. 1982 Mar;128(3):1382–1385. [PubMed] [Google Scholar]
  127. Wang B. S., Zheng C. X., Heacock E. H., Tilney N. L., Strom T. B., Mannick J. A. Inhibition of the production of a soluble helper mediator by cyclosporin A results in the failure to generate alloreactive cytolytic cells in mixed-lymphocyte culture. Clin Immunol Immunopathol. 1983 May;27(2):160–169. doi: 10.1016/0090-1229(83)90066-1. [DOI] [PubMed] [Google Scholar]
  128. Webster L. M., Thomson A. W. Augmentation of delayed-type hypersensitivity to high dose sheep erythrocytes by cyclosporin A in the mouse: influence of drug dosage and route of administration and analysis of spleen cell populations. Clin Exp Immunol. 1988 Jan;71(1):149–154. [PMC free article] [PubMed] [Google Scholar]
  129. Webster L. M., Thomson A. W. Cyclosporin A prevents suppression of delayed-type hypersensitivity in mice immunized with high-dose sheep erythrocytes. Immunology. 1987 Mar;60(3):409–414. [PMC free article] [PubMed] [Google Scholar]
  130. Webster L. M., Thomson A. W. Stimulation of human blood mononuclear cell procoagulant activity by cyclosporin A. Int Arch Allergy Appl Immunol. 1986;81(4):371–374. doi: 10.1159/000234166. [DOI] [PubMed] [Google Scholar]
  131. Weinbaum D. L., Kaplan S. S., Zdziarski U., Rinaldo C. R., Jr, Schroeder K. K. Human polymorphonuclear leukocyte interaction with cyclosporine A. Infect Immun. 1984 Mar;43(3):791–794. doi: 10.1128/iai.43.3.791-794.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Weiss J., Schwinzer B., Kirchner H., Gemsa D., Resch K. Effects of cyclosporin A on functions of specific murine T cell clones: inhibition of proliferation, lymphokine secretion and cytotoxicity. Immunobiology. 1986 Apr;171(3):234–251. doi: 10.1016/S0171-2985(86)80007-9. [DOI] [PubMed] [Google Scholar]
  133. Wenger R. Cyclosporine and analogues: structural requirements for immunosuppressive activity. Transplant Proc. 1986 Dec;18(6 Suppl 5):213–218. [PubMed] [Google Scholar]
  134. Whisler R. L., Lindsey J. A., Proctor K. V., Newhouse Y. G., Cornwell D. G. The impaired ability of human monocytes to stimulate autologous and allogeneic mixed lymphocyte reactions after exposure to cyclosporine. Associated alterations of HLA-DR expression and physical characteristics of monocytes. Transplantation. 1985 Jul;40(1):57–61. doi: 10.1097/00007890-198507000-00012. [DOI] [PubMed] [Google Scholar]
  135. Wilkinson P. C., Higgins A. Cyclosporin A inhibits mitogen-activated but not phorbol ester-activated locomotion of human lymphocytes. Immunology. 1987 Jul;61(3):311–316. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES